Analytical Review on Raloxifene -An Estrogen Receptor Modulator in Different Pharmaceutical Formulations and Biological Fluids
Journal Title: JOURNAL OF PHARMACEUTICAL TECHNOLOGY, RESEARCH AND MANAGEMENT - Year 2017, Vol 5, Issue 1
Abstract
Raloxifene (RLX) is an oral selective estrogen receptor modulator (SERM). It is showing estrogenic action on bone and anti-estrogenic action on uterus and breast. An extensive literature has been published for analysis of RLX in different pharmaceutical formulations. This review article endeavor to provide the detail account on analytical methods for RLX and also validation details for its readers. It further helps to avoid costly chemicals and time consuming exercises for further investigation of RLX.
Authors and Affiliations
Ashwini v. Gujar , Anand B. Mundada , Atul A. Shirkhedkar
Keywords
Related Articles
- EP ID EP596722
- DOI 10.15415/jptrm.2017.51004
- Views 151
- Downloads 0
Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders
Epigenetic modification acetylation or deacetylation of histone considered as an important element in various disorders. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are the enzymes which catalyse t...
Cold Chain: A Lynchpin of National Immunization Program
Cold chain management (CCM), a lynchpin of National Immunization Program (NIP) is to deliver the vaccines or other immunological products/ vaccines to right people, at right place, and in right time ineffective m...
Estimation of Delafloxacin Using Derivative Spectrophotometry and Area Under Curve in Bulk Material and in Laboratory Mixture
Simple, specific, rapid and accurate UV-spectrophotometric methods have been developed using a solvent acetonitrile (50 %) to determine delafloxacin in bulk material and in laboratory mixture. “Method A” is zero order de...
Preparation and Evaluation of Chitosan and PLGA Based Implants for the Delivery of Cefotaxime
The poor bioavailability of cefotaxime and limitation of conventional system limits the delivery of antibacterial drug cefotaxime for bone infection treatment. In the current study in situ chitosan implant containing cef...
A Study of Prescribing Habits of Low Molecular Weight Heparin in Cardiovascular Disease in Tertiary Care Hospital
Background and Objective: Cardiovascular Diseases (CVDs) are the leading non-communicable diseases and also leading cause of morbidity and mortality worldwide. Low Molecular Weight Heparin (LMWHs) is frequen...